Experience real-time quotes, in-depth charts, and analyst ratings

Open account

MARKET

AEMD

Aethlon Medical

NASDAQ

1.480

+0.020

+1.37%

Closed 17:55 04/22 EDT

OPEN

1.470

PREV CLOSE

1.460

HIGH

1.480

LOW

1.421

VOLUME

1.44K

TURNOVER

52 WEEK HIGH

5.92

52 WEEK LOW

1.350

MARKET CAP

3.88M

P/E (TTM)

-0.2944

Weekly Report: what happened at AEMD last week (0415-0419)?

Weekly Report · 1d ago

Weekly Report: what happened at AEMD last week (0408-0412)?

Weekly Report · 04/15 11:23

WHO's Tedros Adhanom Ghebreyesus Posts On X "In #DRC alone, more than 4500 cases of #mpox and almost 300 deaths have been reported this year. That is triple the number reported at this time last year. The recent surge in cases and deaths among children is of particular concern, along with the re-emergence of Clade One in central Africa...."

Benzinga · 04/11 14:09

Weekly Report: what happened at AEMD last week (0401-0405)?

Weekly Report · 04/08 11:28

BRIEF-Aethlon Medical Files For Offering Of Up To 4.65 Million Shares Of Common Stock

Aethlon Medical Inc Files For Offering Of Up To 4.65 Million Shares Of Common Stock. The company is a subsidiary of Aethlon Pharmaceuticals Inc. The offering is expected to raise up to $100 million in the first quarter of 2013. The shares are expected to be sold on the Nasdaq.

Reuters · 04/05 21:33

Weekly Report: what happened at AEMD last week (0325-0329)?

Weekly Report · 04/01 11:26

Weekly Report: what happened at AEMD last week (0318-0322)?

Weekly Report · 03/25 11:29

Aethlon Medical files to sell common stock, warrants

Seeking Alpha · 03/22 21:22

About AEMD

Aethlon Medical, Inc. (Aethlon) is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections suppression, seed the spread of metastasis and inhibit the benefit of cancer therapies. The Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression. Hemopurifier helps to bind and clear multiple different glycosylated viruses, such as human immunodeficiency virus (HIV), hepatitis C virus (HCV), Dengue, West Nile, multiple strains of influenza, Ebola, Chikungunya, smallpox, monkeypox, multiple herpes viruses, a MERS-CoV related pseudovirus, and others. Hemopurifier is used as a device for two independent indications: the treatment of individuals with advanced or metastatic cancer and the treatment of life threating viruses that are not approved therapies.

Webull offers Aethlon Medical, Inc. stock information, including NASDAQ: AEMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AEMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AEMD stock methods without spending real money on the virtual paper trading platform.